Total Payments
$8,866
2024 Payments
$640.36
Companies
46
Transactions
422
Medicare Patients
6,848
Medicare Billing
$1.3M
Payment Breakdown by Category
Food & Beverage$8,383 (94.6%)
Education$269.32 (3.0%)
Travel$213.59 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,383 | 413 | 94.6% |
| Education | $269.32 | 6 | 3.0% |
| Travel and Lodging | $213.59 | 3 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,188 | 139 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $971.04 | 44 | $0 (2022) |
| Mylan Specialty L.P. | $595.13 | 35 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $495.11 | 25 | $0 (2024) |
| Genentech USA, Inc. | $367.44 | 14 | $0 (2020) |
| Sunovion Pharmaceuticals Inc. | $304.26 | 22 | $0 (2018) |
| Grifols USA, LLC | $262.16 | 11 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $255.02 | 14 | $0 (2020) |
| Allergan Inc. | $248.10 | 10 | $0 (2019) |
| Olympus Corporation of the Americas | $232.34 | 5 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $640.36 | 19 | Abbott Laboratories ($180.19) |
| 2023 | $537.19 | 11 | GlaxoSmithKline, LLC. ($231.53) |
| 2022 | $409.55 | 20 | GlaxoSmithKline, LLC. ($162.86) |
| 2021 | $649.13 | 27 | GlaxoSmithKline, LLC. ($177.79) |
| 2020 | $624.91 | 34 | GlaxoSmithKline, LLC. ($274.68) |
| 2019 | $1,817 | 100 | GlaxoSmithKline, LLC. ($451.00) |
| 2018 | $2,047 | 103 | GlaxoSmithKline, LLC. ($331.89) |
| 2017 | $2,140 | 108 | GlaxoSmithKline, LLC. ($381.76) |
All Payment Transactions
422 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $25.81 | General |
| Category: NEUROLOGY | ||||||
| 10/17/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: NEUROLOGY | ||||||
| 09/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.39 | General |
| Category: RESPIRATORY | ||||||
| 09/10/2024 | Abbott Laboratories | ENSITE (Device) | Education | In-kind items and services | $180.19 | General |
| Category: Electrophysiology | ||||||
| 09/10/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: RESPIRATORY | ||||||
| 08/20/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 07/17/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.11 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: RESPIRATORY | ||||||
| 06/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $18.56 | General |
| Category: IMMUNOLOGY | ||||||
| 06/25/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $0.92 | General |
| Category: IMMUNOLOGY | ||||||
| 06/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: RESPIRATORY | ||||||
| 06/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Respiratory | ||||||
| 05/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.14 | General |
| Category: RESPIRATORY | ||||||
| 03/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: RESPIRATORY | ||||||
| 03/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $122.11 | General |
| Category: Diabetes | ||||||
| 02/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Travel and Lodging | Cash or cash equivalent | $13.54 | General |
| Category: Diabetes | ||||||
| 01/18/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $22.65 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/22/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.68 | General |
| Category: RESPIRATORY | ||||||
| 08/16/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/01/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: RESPIRATORY | ||||||
| 06/20/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.71 | General |
| Category: RESPIRATORY | ||||||
| 06/13/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,801 | 3,281 | $690,039 | $340,677 |
| 2022 | 16 | 1,891 | 3,397 | $713,426 | $349,268 |
| 2021 | 14 | 1,677 | 3,252 | $710,795 | $358,632 |
| 2020 | 14 | 1,479 | 2,607 | $571,188 | $277,788 |
Total Patients
6,848
Total Services
12,537
Medicare Billing
$1.3M
Procedure Codes
58
All Medicare Procedures & Services
58 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 720 | 1,394 | $238,264 | $138,930 | 58.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 201 | 436 | $189,224 | $76,610 | 40.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 235 | 706 | $113,666 | $70,186 | 61.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 135 | 135 | $35,370 | $16,801 | 47.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 76 | 77 | $24,024 | $10,859 | 45.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 129 | 134 | $42,880 | $10,238 | 23.9% |
| 94375 | Test to measure rate of airflow | Office | 2023 | 159 | 243 | $16,235 | $7,522 | 46.3% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 29 | 30 | $11,564 | $2,066 | 17.9% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 26 | 28 | $3,138 | $1,913 | 61.0% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 12 | 14 | $2,383 | $1,608 | 67.5% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 14 | 14 | $7,602 | $1,544 | 20.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 14 | $2,895 | $1,415 | 48.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 21 | 24 | $1,010 | $614.60 | 60.9% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 31 | 32 | $1,784 | $371.84 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 676 | 1,300 | $222,300 | $131,192 | 59.0% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 191 | 468 | $203,112 | $85,362 | 42.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 294 | 805 | $129,605 | $69,626 | 53.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 167 | 167 | $43,754 | $20,781 | 47.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 77 | 81 | $25,272 | $13,435 | 53.2% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 136 | 141 | $45,120 | $11,270 | 25.0% |
| 94375 | Test to measure rate of airflow | Office | 2022 | 165 | 245 | $16,415 | $8,041 | 49.0% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 17 | 18 | $3,096 | $2,129 | 68.8% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 26 | 27 | $10,827 | $1,916 | 17.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 17 | 17 | $3,604 | $1,823 | 50.6% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 25 | 25 | $2,825 | $1,528 | 54.1% |
About Dr. Ashish Patel, MD
Dr. Ashish Patel, MD is a Pulmonary Disease healthcare provider based in Pasadena, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104023977.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ashish Patel, MD has received a total of $8,866 in payments from pharmaceutical and medical device companies, with $640.36 received in 2024. These payments were reported across 422 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($8,383).
As a Medicare-enrolled provider, Patel has provided services to 6,848 Medicare beneficiaries, totaling 12,537 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 58 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Pasadena, CA
- Active Since 06/27/2007
- Last Updated 03/07/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1104023977
Products in Payments
- TRELEGY ELLIPTA (Drug) $900.69
- STIOLTO RESPIMAT (Drug) $616.62
- ANORO (Drug) $490.61
- NUCALA (Biological) $390.15
- SYMBICORT (Drug) $360.08
- Yupelri (Drug) $324.89
- EVIS EXERA (Device) $232.34
- GIAPREZA (Drug) $228.90
- BEVYXXA (Drug) $226.70
- ZERBAXA (Drug) $224.84
- STIOLTO (Drug) $216.69
- BREO (Drug) $203.58
- ENSITE (Device) $180.19
- ELIQUIS (Drug) $170.30
- Prolastin-C Liquid (Biological) $167.31
- Esbriet (Biological) $163.59
- TUDORZA PRESSAIR (Drug) $154.56
- BROVANA (Drug) $137.28
- YUPELRI (Drug) $136.46
- MOUNJARO (Drug) $135.65
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Pasadena
Rajkumar Dasgupta, M.d, M.D
Pulmonary Disease — Payments: $916,165
Pulmonary Disease $916,165
Dr. Donald Kroe, M.d, M.D
Pulmonary Disease — Payments: $9,010
Pulmonary Disease $9,010
Dr. Michael Gurevitch, M.d, M.D
Pulmonary Disease — Payments: $8,728
Pulmonary Disease $8,728
Pang-Chieh Eu, M.d, M.D
Pulmonary Disease — Payments: $1,732
Pulmonary Disease $1,732
Magdalena Arenas, Md, MD
Pulmonary Disease — Payments: $1,199
Pulmonary Disease $1,199
Chitra Ramakrishnan, M.d, M.D
Pulmonary Disease — Payments: $834.80
Pulmonary Disease $834.80